TROV

TrovaGene, Inc. Press Releases

$8.13
*  
0.22
2.63%
Get TROV Alerts
*Delayed - data as of Jul. 29, 2015 13:03 ET  -  Find a broker to begin trading TROV now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    TROV Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Trovagene Schedules Release of Second Quarter 2015 Financial Results and Investor Conference Call
7/23/2015 8:15:00 AM - PR Newswire
▼-18.62 % Price Change since this news event. The Volume Ratio is 1.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene, Inc. Announces Closing of Public Offering of Common Stock
7/22/2015 10:12:00 AM - PR Newswire
▼-14.33 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene, Inc. Announces Pricing of Public Offering of Common Stock
7/17/2015 9:00:00 AM - PR Newswire
▼-8.65 % Price Change since this news event. The Volume Ratio is 8.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene, Inc. Announces Public Offering of Common Stock
7/16/2015 4:29:00 PM - PR Newswire
▼-18.37 % Price Change since this news event. The Volume Ratio is 8.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform
7/8/2015 8:10:00 AM - PR Newswire
▼-15.05 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene Inc. to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
7/7/2015 8:05:00 AM - PR Newswire
▼-19.43 % Price Change since this news event. The Volume Ratio is 0.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes
6/29/2015 8:05:00 AM - PR Newswire
▼-11.05 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences
6/8/2015 8:05:00 AM - PR Newswire
▼-29.24 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting
5/28/2015 8:05:00 AM - PR Newswire
▼-27.35 % Price Change since this news event. The Volume Ratio is 2.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Clinical Utility of Trovagene's Urine-Based Liquid Biopsy Platform to Be Highlighted at the American Society of Clinical Oncology Meeting
5/13/2015 5:01:00 PM - PR Newswire
▼-27.35 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day